nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—POMC—locus ceruleus—attention deficit hyperactivity disorder	0.134	0.272	CbGeAlD
Loperamide—POMC—autonomic nervous system—attention deficit hyperactivity disorder	0.0714	0.145	CbGeAlD
Loperamide—CALM1—autonomic nervous system—attention deficit hyperactivity disorder	0.0194	0.0393	CbGeAlD
Loperamide—POMC—forebrain—attention deficit hyperactivity disorder	0.0166	0.0337	CbGeAlD
Loperamide—CACNA1A—forebrain—attention deficit hyperactivity disorder	0.0159	0.0322	CbGeAlD
Loperamide—POMC—cardiovascular system—attention deficit hyperactivity disorder	0.0141	0.0285	CbGeAlD
Loperamide—POMC—midbrain—attention deficit hyperactivity disorder	0.011	0.0222	CbGeAlD
Loperamide—OPRD1—forebrain—attention deficit hyperactivity disorder	0.00918	0.0186	CbGeAlD
Loperamide—POMC—nervous system—attention deficit hyperactivity disorder	0.00903	0.0183	CbGeAlD
Loperamide—OPRK1—forebrain—attention deficit hyperactivity disorder	0.0088	0.0178	CbGeAlD
Loperamide—POMC—central nervous system—attention deficit hyperactivity disorder	0.0087	0.0176	CbGeAlD
Loperamide—CACNA1A—nervous system—attention deficit hyperactivity disorder	0.00862	0.0175	CbGeAlD
Loperamide—POMC—cerebellum—attention deficit hyperactivity disorder	0.0085	0.0172	CbGeAlD
Loperamide—CACNA1A—central nervous system—attention deficit hyperactivity disorder	0.0083	0.0168	CbGeAlD
Loperamide—CACNA1A—cerebellum—attention deficit hyperactivity disorder	0.00811	0.0164	CbGeAlD
Loperamide—POMC—brain—attention deficit hyperactivity disorder	0.0069	0.014	CbGeAlD
Loperamide—CACNA1A—brain—attention deficit hyperactivity disorder	0.00659	0.0133	CbGeAlD
Loperamide—OPRM1—forebrain—attention deficit hyperactivity disorder	0.00626	0.0127	CbGeAlD
Loperamide—OPRD1—nervous system—attention deficit hyperactivity disorder	0.00498	0.0101	CbGeAlD
Loperamide—OPRD1—central nervous system—attention deficit hyperactivity disorder	0.0048	0.00972	CbGeAlD
Loperamide—OPRK1—nervous system—attention deficit hyperactivity disorder	0.00478	0.00967	CbGeAlD
Loperamide—OPRK1—central nervous system—attention deficit hyperactivity disorder	0.0046	0.00931	CbGeAlD
Loperamide—CALM2—forebrain—attention deficit hyperactivity disorder	0.00454	0.0092	CbGeAlD
Loperamide—CALM1—forebrain—attention deficit hyperactivity disorder	0.00452	0.00916	CbGeAlD
Loperamide—OPRK1—cerebellum—attention deficit hyperactivity disorder	0.0045	0.0091	CbGeAlD
Loperamide—OPRM1—midbrain—attention deficit hyperactivity disorder	0.00413	0.00837	CbGeAlD
Loperamide—CALM2—cardiovascular system—attention deficit hyperactivity disorder	0.00384	0.00778	CbGeAlD
Loperamide—CALM1—cardiovascular system—attention deficit hyperactivity disorder	0.00382	0.00774	CbGeAlD
Loperamide—CALM3—midbrain—attention deficit hyperactivity disorder	0.00382	0.00774	CbGeAlD
Loperamide—OPRD1—brain—attention deficit hyperactivity disorder	0.00381	0.00771	CbGeAlD
Loperamide—OPRK1—brain—attention deficit hyperactivity disorder	0.00365	0.0074	CbGeAlD
Loperamide—OPRM1—nervous system—attention deficit hyperactivity disorder	0.0034	0.00688	CbGeAlD
Loperamide—OPRM1—central nervous system—attention deficit hyperactivity disorder	0.00327	0.00663	CbGeAlD
Loperamide—Haloperidol—DRD4—attention deficit hyperactivity disorder	0.00307	0.215	CrCbGaD
Loperamide—CALM2—midbrain—attention deficit hyperactivity disorder	0.003	0.00608	CbGeAlD
Loperamide—CALM1—midbrain—attention deficit hyperactivity disorder	0.00299	0.00605	CbGeAlD
Loperamide—CALM3—cerebellum—attention deficit hyperactivity disorder	0.00296	0.00599	CbGeAlD
Loperamide—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.00286	0.00578	CbGeAlD
Loperamide—Haloperidol—HTR1B—attention deficit hyperactivity disorder	0.00273	0.191	CrCbGaD
Loperamide—Haloperidol—DRD3—attention deficit hyperactivity disorder	0.00265	0.185	CrCbGaD
Loperamide—Haloperidol—DRD1—attention deficit hyperactivity disorder	0.0026	0.182	CrCbGaD
Loperamide—OPRM1—brain—attention deficit hyperactivity disorder	0.0026	0.00526	CbGeAlD
Loperamide—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00251	0.00508	CbGeAlD
Loperamide—CALM2—nervous system—attention deficit hyperactivity disorder	0.00247	0.00499	CbGeAlD
Loperamide—CALM1—nervous system—attention deficit hyperactivity disorder	0.00246	0.00497	CbGeAlD
Loperamide—CALM3—brain—attention deficit hyperactivity disorder	0.0024	0.00486	CbGeAlD
Loperamide—CALM2—central nervous system—attention deficit hyperactivity disorder	0.00238	0.00481	CbGeAlD
Loperamide—CALM1—central nervous system—attention deficit hyperactivity disorder	0.00236	0.00479	CbGeAlD
Loperamide—CALM2—cerebellum—attention deficit hyperactivity disorder	0.00232	0.0047	CbGeAlD
Loperamide—CALM1—cerebellum—attention deficit hyperactivity disorder	0.00231	0.00468	CbGeAlD
Loperamide—CALM2—brain—attention deficit hyperactivity disorder	0.00189	0.00382	CbGeAlD
Loperamide—CALM1—brain—attention deficit hyperactivity disorder	0.00188	0.0038	CbGeAlD
Loperamide—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.00183	0.00371	CbGeAlD
Loperamide—Haloperidol—DRD2—attention deficit hyperactivity disorder	0.00183	0.128	CrCbGaD
Loperamide—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00181	0.00366	CbGeAlD
Loperamide—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.00177	0.00358	CbGeAlD
Loperamide—CYP2C8—brain—attention deficit hyperactivity disorder	0.00156	0.00316	CbGeAlD
Loperamide—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00153	0.00309	CbGeAlD
Loperamide—Haloperidol—HTR2A—attention deficit hyperactivity disorder	0.00142	0.0991	CrCbGaD
Loperamide—CYP2B6—brain—attention deficit hyperactivity disorder	0.0014	0.00284	CbGeAlD
Loperamide—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00138	0.0028	CbGeAlD
Loperamide—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00136	0.00276	CbGeAlD
Loperamide—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00133	0.0027	CbGeAlD
Loperamide—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00131	0.00266	CbGeAlD
Loperamide—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00128	0.0026	CbGeAlD
Loperamide—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00119	0.00241	CbGeAlD
Loperamide—CYP2D6—brain—attention deficit hyperactivity disorder	0.00104	0.00211	CbGeAlD
Loperamide—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00098	0.00198	CbGeAlD
Loperamide—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000944	0.00191	CbGeAlD
Loperamide—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000922	0.00187	CbGeAlD
Loperamide—ABCB1—brain—attention deficit hyperactivity disorder	0.000749	0.00152	CbGeAlD
Loperamide—OPRK1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000253	0.000515	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000253	0.000514	CbGpPWpGaD
Loperamide—CALM1—Immune System—STUB1—attention deficit hyperactivity disorder	0.000247	0.000502	CbGpPWpGaD
Loperamide—CALM2—Immune System—STUB1—attention deficit hyperactivity disorder	0.000247	0.000502	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000245	0.000498	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000244	0.000496	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000241	0.00049	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00024	0.000488	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000238	0.000484	CbGpPWpGaD
Loperamide—CALM3—Disease—STUB1—attention deficit hyperactivity disorder	0.000236	0.000479	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000236	0.000479	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000235	0.000478	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000232	0.000472	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000232	0.000472	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00023	0.000468	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000229	0.000466	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000228	0.000464	CbGpPWpGaD
Loperamide—CALM1—Disease—STUB1—attention deficit hyperactivity disorder	0.000228	0.000463	CbGpPWpGaD
Loperamide—CALM2—Disease—STUB1—attention deficit hyperactivity disorder	0.000228	0.000463	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000227	0.000462	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000227	0.000462	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000224	0.000456	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000224	0.000456	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000222	0.000451	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000221	0.00045	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00022	0.000447	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00022	0.000447	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000214	0.000435	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000212	0.000432	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000212	0.000432	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000211	0.00043	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00021	0.000427	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000207	0.000421	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000206	0.000419	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000204	0.000416	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000204	0.000416	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000204	0.000414	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000201	0.000409	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000195	0.000396	CbGpPWpGaD
Loperamide—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000194	0.000394	CbGpPWpGaD
Loperamide—CALM3—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000193	0.000393	CbGpPWpGaD
Loperamide—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000192	0.000391	CbGpPWpGaD
Loperamide—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000191	0.000388	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000187	0.000381	CbGpPWpGaD
Loperamide—CALM1—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000187	0.00038	CbGpPWpGaD
Loperamide—CALM2—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000187	0.00038	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000184	0.000374	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000183	0.000373	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000177	0.00036	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000174	0.000354	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000171	0.000348	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00017	0.000347	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00017	0.000345	CbGpPWpGaD
Loperamide—POMC—Metabolism—EP300—attention deficit hyperactivity disorder	0.000167	0.00034	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000165	0.000336	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000165	0.000335	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000164	0.000333	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000164	0.000333	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000163	0.000331	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000162	0.00033	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000161	0.000327	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00016	0.000326	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00016	0.000324	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00016	0.000324	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000158	0.00032	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000158	0.00032	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000155	0.000316	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000155	0.000316	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000149	0.000304	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000149	0.000304	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000147	0.0003	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000145	0.000294	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000144	0.000294	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—EP300—attention deficit hyperactivity disorder	0.000144	0.000293	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000142	0.00029	CbGpPWpGaD
Loperamide—CALM3—RNF mutants show enhanced WNT signaling and proliferation—EP300—attention deficit hyperactivity disorder	0.000142	0.000289	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000142	0.000289	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000142	0.000288	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000141	0.000286	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.00014	0.000284	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000139	0.000282	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000138	0.00028	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000138	0.00028	CbGpPWpGaD
Loperamide—CALM1—RNF mutants show enhanced WNT signaling and proliferation—EP300—attention deficit hyperactivity disorder	0.000138	0.00028	CbGpPWpGaD
Loperamide—CALM2—RNF mutants show enhanced WNT signaling and proliferation—EP300—attention deficit hyperactivity disorder	0.000138	0.00028	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000137	0.000279	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000137	0.000279	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000136	0.000277	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000136	0.000276	CbGpPWpGaD
Loperamide—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000135	0.000274	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000134	0.000273	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000134	0.000273	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000132	0.000269	CbGpPWpGaD
Loperamide—CALM3—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	0.000132	0.000269	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000132	0.000268	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000132	0.000268	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000131	0.000267	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000131	0.000266	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000128	0.000261	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000128	0.000261	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000128	0.00026	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000128	0.00026	CbGpPWpGaD
Loperamide—CALM2—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	0.000128	0.00026	CbGpPWpGaD
Loperamide—CALM1—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	0.000128	0.00026	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000126	0.000257	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000126	0.000256	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000124	0.000253	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000124	0.000252	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000124	0.000252	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000124	0.000252	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000122	0.000249	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000122	0.000248	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000122	0.000248	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000121	0.000246	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00012	0.000245	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00012	0.000245	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00012	0.000245	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00012	0.000244	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00012	0.000244	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000119	0.000242	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000118	0.00024	CbGpPWpGaD
Loperamide—CALM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000117	0.000238	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000117	0.000238	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000116	0.000236	CbGpPWpGaD
Loperamide—CALM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000115	0.000234	CbGpPWpGaD
Loperamide—CALM2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000113	0.00023	CbGpPWpGaD
Loperamide—CALM1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000113	0.00023	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000113	0.00023	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000113	0.00023	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000112	0.000228	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000112	0.000228	CbGpPWpGaD
Loperamide—CALM3—Disease—SNAP25—attention deficit hyperactivity disorder	0.000112	0.000227	CbGpPWpGaD
Loperamide—CALM2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000111	0.000226	CbGpPWpGaD
Loperamide—CALM1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000111	0.000226	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000111	0.000225	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00011	0.000224	CbGpPWpGaD
Loperamide—CALM3—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	0.000109	0.000222	CbGpPWpGaD
Loperamide—CALM1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000108	0.00022	CbGpPWpGaD
Loperamide—CALM2—Disease—SNAP25—attention deficit hyperactivity disorder	0.000108	0.00022	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000107	0.000218	CbGpPWpGaD
Loperamide—CALM2—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	0.000105	0.000214	CbGpPWpGaD
Loperamide—CALM1—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	0.000105	0.000214	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000105	0.000213	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000104	0.00021	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000104	0.00021	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000102	0.000207	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000102	0.000207	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.0001	0.000204	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.62e-05	0.000196	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.61e-05	0.000195	CbGpPWpGaD
Loperamide—CALM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.35e-05	0.00019	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.31e-05	0.000189	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.31e-05	0.000189	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.31e-05	0.000189	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.17e-05	0.000186	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.15e-05	0.000186	CbGpPWpGaD
Loperamide—CALM1—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.05e-05	0.000184	CbGpPWpGaD
Loperamide—CALM2—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.05e-05	0.000184	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.9e-05	0.000181	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	8.87e-05	0.00018	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.87e-05	0.00018	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	8.72e-05	0.000177	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.61e-05	0.000175	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.61e-05	0.000175	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.41e-05	0.000171	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	8.36e-05	0.00017	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.36e-05	0.00017	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	8.22e-05	0.000167	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.14e-05	0.000165	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.14e-05	0.000165	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.14e-05	0.000165	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.12e-05	0.000165	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.11e-05	0.000165	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	7.91e-05	0.000161	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.86e-05	0.00016	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.86e-05	0.00016	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.82e-05	0.000159	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.75e-05	0.000158	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.75e-05	0.000157	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.64e-05	0.000155	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.57e-05	0.000154	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.57e-05	0.000154	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.57e-05	0.000154	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—EP300—attention deficit hyperactivity disorder	7.5e-05	0.000152	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.45e-05	0.000151	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.35e-05	0.00015	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.33e-05	0.000149	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.33e-05	0.000149	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	7.28e-05	0.000148	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—EP300—attention deficit hyperactivity disorder	7.25e-05	0.000147	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—EP300—attention deficit hyperactivity disorder	7.25e-05	0.000147	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	7.23e-05	0.000147	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.2e-05	0.000146	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.2e-05	0.000146	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.11e-05	0.000145	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.11e-05	0.000145	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.09e-05	0.000144	CbGpPWpGaD
Loperamide—CALM3—Metabolism—COMT—attention deficit hyperactivity disorder	7.09e-05	0.000144	CbGpPWpGaD
Loperamide—CALM3—Metabolism—MAOA—attention deficit hyperactivity disorder	7.04e-05	0.000143	CbGpPWpGaD
Loperamide—CALM2—Metabolism—COMT—attention deficit hyperactivity disorder	6.86e-05	0.000139	CbGpPWpGaD
Loperamide—CALM1—Metabolism—COMT—attention deficit hyperactivity disorder	6.86e-05	0.000139	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.85e-05	0.000139	CbGpPWpGaD
Loperamide—CALM1—Metabolism—MAOA—attention deficit hyperactivity disorder	6.81e-05	0.000138	CbGpPWpGaD
Loperamide—CALM2—Metabolism—MAOA—attention deficit hyperactivity disorder	6.81e-05	0.000138	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—EP300—attention deficit hyperactivity disorder	6.75e-05	0.000137	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.75e-05	0.000137	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.68e-05	0.000136	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.63e-05	0.000135	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.63e-05	0.000135	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—EP300—attention deficit hyperactivity disorder	6.53e-05	0.000133	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—EP300—attention deficit hyperactivity disorder	6.53e-05	0.000133	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.36e-05	0.000129	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	6.17e-05	0.000125	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	6.12e-05	0.000124	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.94e-05	0.000121	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.54e-05	0.000113	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	5.46e-05	0.000111	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.46e-05	0.000111	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	5.37e-05	0.000109	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	5.37e-05	0.000109	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	5.33e-05	0.000108	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	5.06e-05	0.000103	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	5.03e-05	0.000102	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5e-05	0.000102	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.86e-05	9.88e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.8e-05	9.76e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.64e-05	9.44e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.64e-05	9.44e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.37e-05	8.88e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.16e-05	8.45e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.11e-05	8.35e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—EP300—attention deficit hyperactivity disorder	3.93e-05	7.99e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—EP300—attention deficit hyperactivity disorder	3.8e-05	7.73e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—EP300—attention deficit hyperactivity disorder	3.8e-05	7.73e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—EP300—attention deficit hyperactivity disorder	3.63e-05	7.38e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—EP300—attention deficit hyperactivity disorder	3.51e-05	7.14e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—EP300—attention deficit hyperactivity disorder	3.51e-05	7.14e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	3.31e-05	6.73e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	3.29e-05	6.68e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	3.12e-05	6.35e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—EP300—attention deficit hyperactivity disorder	3.04e-05	6.18e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—EP300—attention deficit hyperactivity disorder	2.94e-05	5.98e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—EP300—attention deficit hyperactivity disorder	2.94e-05	5.98e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	2.64e-05	5.38e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.54e-05	5.17e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.46e-05	5e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.46e-05	5e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	2.3e-05	4.68e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	2.17e-05	4.41e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.42e-05	2.89e-05	CbGpPWpGaD
